Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Microstructural brain abnormalities in medication-free patients with major depressive disorder: a systematic review and meta-analysis of diffusion tensor imaging.

Jiang J, Zhao YJ, Hu XY, Du MY, Chen ZQ, Wu M, Li KM, Zhu HY, Kumar P, Gong QY.

J Psychiatry Neurosci. 2017 May;42(3):150-163.

2.

Is there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive Disorder.

Young JJ, Silber T, Bruno D, Galatzer-Levy IR, Pomara N, Marmar CR.

Front Psychiatry. 2016 Apr 25;7:72. doi: 10.3389/fpsyt.2016.00072. eCollection 2016. Review.

3.

Voxel-wise meta-analyses of brain blood flow and local synchrony abnormalities in medication-free patients with major depressive disorder.

Chen ZQ, Du MY, Zhao YJ, Huang XQ, Li J, Lui S, Hu JM, Sun HQ, Liu J, Kemp GJ, Gong QY.

J Psychiatry Neurosci. 2015 Nov;40(6):401-11.

4.

The association of post-stroke anhedonia with salivary cortisol levels and stroke lesion in hippocampal/parahippocampal region.

Terroni L, Amaro E Jr, Iosifescu DV, Mattos P, Yamamoto FI, Tinone G, Conforto AB, Sobreiro MF, Guajardo VD, De Lucia MC, Moreira AC, Scaff M, Leite CC, Fraguas R.

Neuropsychiatr Dis Treat. 2015 Feb 3;11:233-42. doi: 10.2147/NDT.S73722. eCollection 2015.

5.

GABAergic control of depression-related brain states.

Luscher B, Fuchs T.

Adv Pharmacol. 2015;73:97-144. doi: 10.1016/bs.apha.2014.11.003. Epub 2015 Jan 14.

6.

Multilevel assessment of the neurobiological threat system in depressed adolescents: interplay between the limbic system and hypothalamic-pituitary-adrenal axis.

Klimes-Dougan B, Eberly LE, Westlund Schreiner M, Kurkiewicz P, Houri A, Schlesinger A, Thomas KM, Mueller BA, Lim KO, Cullen KR.

Dev Psychopathol. 2014 Nov;26(4 Pt 2):1321-35. doi: 10.1017/S0954579414001059.

7.

Cerebral metabolism in major depressive disorder: a voxel-based meta-analysis of positron emission tomography studies.

Su L, Cai Y, Xu Y, Dutt A, Shi S, Bramon E.

BMC Psychiatry. 2014 Nov 19;14:321. doi: 10.1186/s12888-014-0321-9. Review.

8.

Tractography of the brainstem in major depressive disorder using diffusion tensor imaging.

Song YJ, Korgaonkar MS, Armstrong LV, Eagles S, Williams LM, Grieve SM.

PLoS One. 2014 Jan 21;9(1):e84825. doi: 10.1371/journal.pone.0084825. eCollection 2014.

9.

Antistress Effects of the Ethanolic Extract from Cymbopogon schoenanthus Growing Wild in Tunisia.

Ben Othman M, Han J, El Omri A, Ksouri R, Neffati M, Isoda H.

Evid Based Complement Alternat Med. 2013;2013:737401. doi: 10.1155/2013/737401. Epub 2013 Oct 8.

10.

Nobiletin Ameliorates the Deficits in Hippocampal BDNF, TrkB, and Synapsin I Induced by Chronic Unpredictable Mild Stress.

Li J, Zhou Y, Liu BB, Liu Q, Geng D, Weng LJ, Yi LT.

Evid Based Complement Alternat Med. 2013;2013:359682. doi: 10.1155/2013/359682. Epub 2013 Mar 17.

11.

Neural systems approaches to understanding major depressive disorder: an intrinsic functional organization perspective.

Hamilton JP, Chen MC, Gotlib IH.

Neurobiol Dis. 2013 Apr;52:4-11. doi: 10.1016/j.nbd.2012.01.015. Epub 2012 Feb 10. Review.

12.

Glucocorticoids orchestrate divergent effects on mood through adult neurogenesis.

Lehmann ML, Brachman RA, Martinowich K, Schloesser RJ, Herkenham M.

J Neurosci. 2013 Feb 13;33(7):2961-72. doi: 10.1523/JNEUROSCI.3878-12.2013.

13.

Salivary cortisol in women with major depressive disorder under selective serotonin reuptake inhibitors therapy.

Dziurkowska E, Wesolowski M, Dziurkowski M.

Arch Womens Ment Health. 2013 Apr;16(2):139-47. doi: 10.1007/s00737-013-0329-z. Epub 2013 Jan 31.

14.

Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 Balance.

Martino M, Rocchi G, Escelsior A, Fornaro M.

Curr Neuropharmacol. 2012 Jun;10(2):97-123. doi: 10.2174/157015912800604542.

15.

Recruitment of the left hemispheric emotional attention neural network in risk for and protection from depression.

Lisiecka DM, Carballedo A, Fagan AJ, Ferguson Y, Meaney J, Frodl T.

J Psychiatry Neurosci. 2013 Mar;38(2):117-28. doi: 10.1503/jpn.110188.

16.

Do premenopausal women with major depression have low bone mineral density? A 36-month prospective study.

Cizza G, Mistry S, Nguyen VT, Eskandari F, Martinez P, Torvik S, Reynolds JC, Gold PW, Sinaii N, Csako G; POWER Study Group.

PLoS One. 2012;7(7):e40894. Epub 2012 Jul 27. Erratum in: PLoS One. 2012;7(10). doi:10.1371/annotation/193f2b29-b8b0-41e8-808a-290df5577a53. Sinai, Ninet [corrected to Sinaii, Ninet].

17.

Neuroticism, acculturation and the cortisol awakening response in Mexican American adults.

Mangold D, Mintz J, Javors M, Marino E.

Horm Behav. 2012 Jan;61(1):23-30. doi: 10.1016/j.yhbeh.2011.09.009. Epub 2011 Oct 1.

18.

A mouse model of high trait anxiety shows reduced heart rate variability that can be reversed by anxiolytic drug treatment.

Gaburro S, Stiedl O, Giusti P, Sartori SB, Landgraf R, Singewald N.

Int J Neuropsychopharmacol. 2011 Nov;14(10):1341-55. doi: 10.1017/S1461145711000058. Epub 2011 Feb 15.

19.

The cortisol awakening response predicts subclinical depressive symptomatology in Mexican American adults.

Mangold D, Marino E, Javors M.

J Psychiatr Res. 2011 Jul;45(7):902-9. doi: 10.1016/j.jpsychires.2011.01.001. Epub 2011 Feb 5.

20.

Frontocingulate dysfunction in depression: toward biomarkers of treatment response.

Pizzagalli DA.

Neuropsychopharmacology. 2011 Jan;36(1):183-206. doi: 10.1038/npp.2010.166. Epub 2010 Sep 22. Review.

Supplemental Content

Support Center